Seelos Therapeutics, Inc.
Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose

Abstract:

Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of trehalose.